News|Articles|August 31, 2017

ISPE Releases IT GAMP Good Practice Guide

The International Society for Pharmaceutical Engineering announced the release of ISPE GAMP Good Practice Guide: IT Infrastructure Control and Compliance (Second Edition).

The International Society for Pharmaceutical Engineering (ISPE) released the ISPE GAMP Good Practice Guide: IT Infrastructure Control and Compliance (Second Edition), the group announced in an Aug. 31, 2017 press release. This guide provides guidance on meeting regulatory expectations for both traditional and cloud-based information technology (IT) infrastructure platforms.

“The creation of this guide was facilitated by a large cross section of SMEs [subject matter experts] from the life science community, cloud practitioners, regulated companies, consultants, and global regulatory authorities,” said Steve Ferrell, team lead for the Guide, in the press release. “It aligns with GAMP 5 and expands the scope of the original Good Practice Guide to include guidance on the emergence of cloud and virtualized technologies.”

The guide applies a structured approach, including risk management, to the qualification, management, and control of IT Infrastructure platforms. It also offers a scalable framework which can be applied to different platform types to determine the scope of qualification efforts. In addition, it contains an overview of industry best practices for the design, qualification, and operation of an IT Infrastructure with emphasis on the qualification requirements of the major components.

Updated information has been added to reflect the changes in the technologies that make up IT Infrastructure, including:

  • virtualization technologies that allow the sharing of resources

  • cloud computing, including three cloud-based service models

  • delivery of GxP applications “as-a-service”

  • outsourcing and increased use of third party datacenters.

Source: ISPE


Related to this article

Quality inspector walking through processing area with stainless tanks and tablet | Image Credit: ©Surachai -stock.adobe.com
At the PDA/FDA Joint Regulatory Conference 2026, Helen Motamen, MS global head, Sanofi Quality Audit, Inspection, Intelligence & Advocacy, at Sanofi, provided advice for creating a strong internal audit program.
Intravenous therapy; drip chamber in focus against a colorful background | Image Credit: ©Anna Jurkovska -stock.adobe.com
This article explores the historical use of silicone oil in the performance of primary drug product packaging; design of experiment test results for selection of the cleaning agent and CCPs; assessment of visible residue limits and Fourier-transform infrared spectroscopy surface analysis; and setting health-based exposure limits for silicone oil using a non-uniform distribution model, and a previously published permitted daily exposure.